SPECT/CT lymphoscintigraphy can accurately localize the sentinel lymph nodes and the clipped node in breast cancer patients undergoing targeted axillary dissection after neoadjuvant chemotherapy

2024-11-0920220959-8049N/Ahttps://www.ejcancer.com/article/S0959-8049(22)01389-2/fulltexthttps://hdl.handle.net/20.500.14288/9098N/AOncologySPECT/CT lymphoscintigraphy can accurately localize the sentinel lymph nodes and the clipped node in breast cancer patients undergoing targeted axillary dissection after neoadjuvant chemotherapyMeeting Abstract1879-08521037996400210Q12142